Cargando…
Immunotherapy efficacy predictive tool for lung adenocarcinoma based on neural network
BACKGROUND: Remarkably, the anti-cancer efficacy of immunotherapy in lung adenocarcinoma (LUAD) has been demonstrated. However, predicting the beneficiaries of this expensive treatment is still a challenge. MATERIALS AND METHODS: A group of patients (N = 250) diagnosed with LUAD and receiving immuno...
Autores principales: | Li, Wei, Fu, Siyun, Gao, Xiang, Lu, Zhendong, Jin, Renjing, Qin, Na, Zhang, Xinyong, Wu, Yuhua, Li, Weiying, Wang, Jinghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086240/ https://www.ncbi.nlm.nih.gov/pubmed/37056768 http://dx.doi.org/10.3389/fimmu.2023.1141408 |
Ejemplares similares
-
Assessing the efficacy of immunotherapy in lung squamous carcinoma using artificial intelligence neural network
por: Li, Siqi, et al.
Publicado: (2022) -
Research progress of extracellular vesicles as biomarkers in immunotherapy for non-small cell lung cancer
por: Ge, Yang, et al.
Publicado: (2023) -
PCSK9 regulates the efficacy of immune checkpoint therapy in lung cancer
por: Gao, Xiang, et al.
Publicado: (2023) -
Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022) -
Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Zeng, Weibiao, et al.
Publicado: (2023)